Font Size: a A A
Keyword [JAK2V617F]
Result: 41 - 60 | Page: 3 of 4
41. Public Distribution Analysis For Clinic Features And Investigation Of JAK2 V617F、exon12 Point Mutations Of The Patients With Budd-Chiari Syndrome In The North Anhui
42. The Study On Relationship Between JAK2V617F Gene Mutation And CALR Gene Mutation And Clinical Significance Of Classic BCR/ABL Negative Myeloproliferative Neoplasm Patients
43. Detetion And Clinical Significance Of JAK2V617F Mutation In 92 Patients With Chronic Myeloproliferative Neoplasm
44. Clinical Characteristics And Risk Factors For Thrombosis In Patients With BCR/ABL Negative Myeloproliferative
45. The Clinical And Biological Studies Of Myeloproliferative Neoplasms
46. Correlation Study Of VEGF,HIF-1α,PTEN And Angiogenesis In JAK2V617F Positive Myeloroliferative Neoplasms
47. Effect Of IFN-α2b On COX-2 And Angiogenesis In JAK2V617F Positive Myeloproliferative Neoplasms
48. Correlative Study Between JAK2V617F,CALR And MPL Mutation And Thrombosis In Patients With Myeloproliferative Neoplasm
49. Regulation Of Ruxolitinib On Matrix Metalloproteinase In JAK2V617F Positive Myeloproliferative Neoplasmss Cells
50. Changes And Clinical Significance Of Heart Remodeling And Function In Patients With Myeloproliferative Neoplasms
51. Biological Effects Of MPL Or CALR Mutation On Neutrophil Alkaline Phosphatase In Patients With Myeloproliferative Neoplasms
52. The Expression And Clinical Relevance Of JAK2V617F And CALR Gene Mutations In BCR/ABL Fusion Gene Negative Bone Marrow Proliferative Tumors
53. Clinical Application Of Droplet Digital PCR Detection Of JAK2V617F Mutation Load In Myeloproliferative Neoplasms
54. Ⅰ The Effects Of JAK2 Mutant In Atherosclerosis And Thrombosis Ⅱ The Effects Of ω3 Polyunsaturated Fatty Acid Metabolites In Early Nonalcoholic Fatty Liver Disease Progression
55. Clinical Characteristics Of 73 Cases Of BCR-ABL Negative Myeloproliferative Neoplasms
56. Quantitative Proteomics Study On The Phosphorylation Modification Of TMT Markers In Human Cell Line NB4 In Response To The Effects Of JAK2, MPL, And CALR Mutations On NAP Expression
57. JAK2 is not a one trick pony: The JAK2V617F mutation, copy number change and rearrangement of the JAK2 gene is present among Ph-negative MPDs, MDS and B-cell neoplasms
58. Mast cells: Involvement in polycythemia vera-associated pruritus and strain-dependent expression of chymase
59. The Research On The Correlation Between Myeloproliferative Neoplasms Patients JAK2V617F Gene And The Clinical Result Of Blood Cells Separation And Collection Cure Method
60. Effect Of JAK2v617f Gene Mutation On Dendritic Cells And Its Role In JAK2v617f(+)MPN
  <<First  <Prev  Next>  Last>>  Jump to